On the public citation graph

Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer

0 signed · 178 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 121 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-04): 10.1002/ijc.20910 (notice 2013-01-15).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1873-3468.13487openalex-snapshot

Urinary exosomal proteins as (pan‐)cancer biomarkers: insights from the proteome

inferredcites →https://doi.org/10.1002/cam4.293openalex-snapshot

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling

inferredcites →https://doi.org/10.1002/cbin.11292openalex-snapshot

Exosomal miR‐663b targets Ets2‐repressor factor to promote proliferation and the epithelial–mesenchymal transition of bladder cancer cells

inferredcites →https://doi.org/10.1002/cncr.22543openalex-snapshot

Detection of circulating urothelial cancer cells in the blood using the CellSearch System

inferredcites →https://doi.org/10.1002/cncr.31314openalex-snapshot

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA

inferredcites →https://doi.org/10.1002/cyto.990210109openalex-snapshot

Heterogeneity of chromosome 17 and erbB‐2 gene copy number in primary and metastatic bladder cancer

inferredcites →https://doi.org/10.1002/ijc.20910openalex-snapshot

Aberrant methylation of Reprimo in human malignancies

inferredcites →https://doi.org/10.1002/ijc.28654openalex-snapshot

Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma

inferredcites →https://doi.org/10.1002/path.4230openalex-snapshot

Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling

inferredcites →https://doi.org/10.1002/path.4886openalex-snapshot

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification

inferredcites →https://doi.org/10.1002/path.5250openalex-snapshot

Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy

inferredcites →https://doi.org/10.1007/s13277-014-1894-0openalex-snapshot

Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance

inferredcites →https://doi.org/10.1016/j.canlet.2006.12.014openalex-snapshot

Circulating tumor cells (CTC) detection: Clinical impact and future directions

inferredcites →https://doi.org/10.1016/j.canlet.2008.01.038openalex-snapshot

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity

inferredcites →https://doi.org/10.1016/j.ccell.2017.08.005openalex-snapshot

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency

inferredcites →https://doi.org/10.1016/j.cell.2017.09.007openalex-snapshot

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

inferredcites →https://doi.org/10.1016/j.cell.2018.03.017openalex-snapshot

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

inferredcites →https://doi.org/10.1016/j.cell.2018.07.036openalex-snapshot

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

inferredcites →https://doi.org/10.1016/j.clinbiochem.2018.11.009openalex-snapshot

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer

inferredcites →https://doi.org/10.1016/j.ctrv.2019.101894openalex-snapshot

Comprehensive intra-individual genomic and transcriptional heterogeneity: Evidence-based Colorectal Cancer Precision Medicine

inferredcites →https://doi.org/10.1016/j.ebiom.2016.06.032openalex-snapshot

Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer

inferredcites →https://doi.org/10.1016/j.ejca.2005.07.019openalex-snapshot

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma

inferredcites →https://doi.org/10.1016/j.euo.2019.02.004openalex-snapshot

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study

inferredcites →https://doi.org/10.1016/j.euo.2019.08.004openalex-snapshot

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer

inferredcites →https://doi.org/10.1016/j.eururo.2015.01.014openalex-snapshot

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

inferredcites →https://doi.org/10.1016/j.eururo.2016.01.007openalex-snapshot

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

inferredcites →https://doi.org/10.1016/j.eururo.2016.12.016openalex-snapshot

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

inferredcites →https://doi.org/10.1016/j.eururo.2017.03.030openalex-snapshot

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

inferredcites →https://doi.org/10.1016/j.eururo.2017.09.011openalex-snapshot

Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis

inferredcites →https://doi.org/10.1016/j.eururo.2018.06.028openalex-snapshot

Evolution of PD-1 and PD-L1 Gene and Protein Expression in Primary Tumors and Corresponding Liver Metastases of Metastatic Bladder Cancer

inferredcites →https://doi.org/10.1016/j.eururo.2018.08.027openalex-snapshot

Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors

inferredcites →https://doi.org/10.1016/j.eururo.2018.09.002openalex-snapshot

Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

inferredcites →https://doi.org/10.1016/j.eururo.2018.09.003openalex-snapshot

Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants

inferredcites →https://doi.org/10.1016/j.eururo.2019.01.009openalex-snapshot

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

inferredcites →https://doi.org/10.1016/j.eururo.2019.01.011openalex-snapshot

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer

inferredcites →https://doi.org/10.1016/j.eururo.2019.09.006openalex-snapshot

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

inferredcites →https://doi.org/10.1016/j.juro.2007.08.091openalex-snapshot

Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer

inferredcites →https://doi.org/10.1016/j.juro.2012.03.122openalex-snapshot

Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer

inferredcites →https://doi.org/10.1016/j.molonc.2016.08.003openalex-snapshot

Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma

inferredcites →https://doi.org/10.1016/j.nano.2019.102100openalex-snapshot

Label-free liquid biopsy based on blood circulating DNA detection using SERS-based nanotechnology for nasopharyngeal cancer screening

inferredcites →https://doi.org/10.1016/j.semcancer.2017.04.007openalex-snapshot

How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case

inferredcites →https://doi.org/10.1016/j.urolonc.2005.11.023openalex-snapshot

Molecular markers in bladder cancer: A critical appraisal

inferredcites →https://doi.org/10.1016/j.urolonc.2018.10.023openalex-snapshot

Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria

inferredcites →https://doi.org/10.1016/s0090-4295(02)02136-2openalex-snapshot

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

inferredcites →https://doi.org/10.1021/pr3008732openalex-snapshot

Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients

inferredcites →https://doi.org/10.1038/ejhg.2009.230openalex-snapshot

Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression

inferredcites →https://doi.org/10.1038/ejhg.2015.281openalex-snapshot

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA

inferredcites →https://doi.org/10.1038/modpathol.3800177openalex-snapshot

CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer

inferredcites →https://doi.org/10.1038/nature08989openalex-snapshot

Genome remodelling in a basal-like breast cancer metastasis and xenograft

inferredcites →https://doi.org/10.1038/nature09515openalex-snapshot

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

inferredcites →https://doi.org/10.1038/nature12213openalex-snapshot

Mutational heterogeneity in cancer and the search for new cancer-associated genes

inferredcites →https://doi.org/10.1038/nature12477openalex-snapshot

Signatures of mutational processes in human cancer

inferredcites →https://doi.org/10.1038/nature12625openalex-snapshot

The causes and consequences of genetic heterogeneity in cancer evolution

inferredcites →https://doi.org/10.1038/nature22364openalex-snapshot

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

inferredcites →https://doi.org/10.1038/nbt.3520openalex-snapshot

Integrated digital error suppression for improved detection of circulating tumor DNA

inferredcites →https://doi.org/10.1038/ncomms9760openalex-snapshot

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer

inferredcites →https://doi.org/10.1038/ng.2891openalex-snapshot

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

inferredcites →https://doi.org/10.1038/ng.3315openalex-snapshot

Spatial genomic heterogeneity within localized, multifocal prostate cancer

inferredcites →https://doi.org/10.1038/nm.3519openalex-snapshot

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

inferredcites →https://doi.org/10.1038/nrc.2017.7openalex-snapshot

Liquid biopsies come of age: towards implementation of circulating tumour DNA

inferredcites →https://doi.org/10.1038/nrdp.2017.22openalex-snapshot

Bladder cancer

inferredcites →https://doi.org/10.1038/s41422-019-0195-yopenalex-snapshot

Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma

inferredcites →https://doi.org/10.1038/s41568-019-0180-2openalex-snapshot

Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells

inferredcites →https://doi.org/10.1038/s41585-019-0237-8openalex-snapshot

Towards precision oncology in advanced prostate cancer

inferredcites →https://doi.org/10.1038/s41591-018-0269-2openalex-snapshot

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

inferredcites →https://doi.org/10.1038/s41591-019-0561-9openalex-snapshot

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

inferredcites →https://doi.org/10.1038/s41598-017-05623-3openalex-snapshot

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer

inferredcites →https://doi.org/10.1038/s41598-017-11291-0openalex-snapshot

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer

inferredcites →https://doi.org/10.1038/s41598-020-62753-xopenalex-snapshot

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging

inferredcites →https://doi.org/10.1038/srep34446openalex-snapshot

Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma

inferredcites →https://doi.org/10.1039/c8lc01185kopenalex-snapshot

Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer

inferredcites →https://doi.org/10.1056/nejmoa022148openalex-snapshot

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

inferredcites →https://doi.org/10.1056/nejmoa1113205openalex-snapshot

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

inferredcites →https://doi.org/10.1073/pnas.1313580111openalex-snapshot

Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer

inferredcites →https://doi.org/10.1097/ju.0000000000000936.013openalex-snapshot

MP61-13 DO URINARY-BASED MOLECULAR BIOMARKER HAVE THE ABILITY TO PREDICT THE GRADE OF NON-MUSCLE INVASIVE BLADDER CANCER GRADE?

inferredcites →https://doi.org/10.1097/sla.0000000000001937openalex-snapshot

Intratumoral Genetic Heterogeneity in Rectal Cancer

inferredcites →https://doi.org/10.1101/488460openalex-snapshot

The consensus molecular classification of muscle-invasive bladder cancer

inferredcites →https://doi.org/10.1111/bju.14808openalex-snapshot

Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA : a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification

inferredcites →https://doi.org/10.1111/cas.14000openalex-snapshot

Diagnostic potential of TERT promoter and FGFR 3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma

inferredcites →https://doi.org/10.1111/cas.14155openalex-snapshot

Genomic profile of urine has high diagnostic sensitivity compared to cytology in non‐invasive urothelial bladder cancer

inferredcites →https://doi.org/10.1111/jcmm.13578openalex-snapshot

Cell‐free lncRNA expression signatures in urine serve as novel non‐invasive biomarkers for diagnosis and recurrence prediction of bladder cancer

inferredcites →https://doi.org/10.1111/jcmm.14042openalex-snapshot

Evaluation of serum exosomal Lnc RNA ‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer

inferredcites →https://doi.org/10.1126/science.1253462openalex-snapshot

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

inferredcites →https://doi.org/10.1126/science.1256930openalex-snapshot

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

inferredcites →https://doi.org/10.1126/scitranslmed.aaa8507openalex-snapshot

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

inferredcites →https://doi.org/10.1158/0008-5472.can-16-0436openalex-snapshot

Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma

inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-1031openalex-snapshot

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses

inferredcites →https://doi.org/10.1158/1078-0432.ccr-17-1140openalex-snapshot

Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer

inferredcites →https://doi.org/10.1158/1078-0432.ccr-18-0386openalex-snapshot

Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab

inferredcites →https://doi.org/10.1158/2159-8290.cd-15-1483openalex-snapshot

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

inferredcites →https://doi.org/10.1158/2159-8290.cd-18-0825openalex-snapshot

Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA

inferredcites →https://doi.org/10.1172/jci130892openalex-snapshot

Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer

inferredcites →https://doi.org/10.1186/s12943-015-0466-2openalex-snapshot

MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer

inferredcites →https://doi.org/10.1186/s12943-018-0893-yopenalex-snapshot

Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer

inferredcites →https://doi.org/10.1186/s40425-019-0619-8openalex-snapshot

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes

inferredcites →https://doi.org/10.1186/s40880-018-0344-6openalex-snapshot

Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2‐positive metastatic gastric cancer

inferredcites →https://doi.org/10.1186/s40880-019-0356-xopenalex-snapshot

Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

inferredcites →https://doi.org/10.1200/jco.18.01148openalex-snapshot

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

inferredcites →https://doi.org/10.1200/jco.2013.31.15_suppl.tps4588openalex-snapshot

The Borealis-2 clinical trial: A randomized phase II study of OGX-427 plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer.

inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.tps4593openalex-snapshot

The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer.

inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.4503openalex-snapshot

First-line randomized phase II study of gemcitabine/cisplatin plus apatorsen or placebo in patients with advanced bladder cancer: The International Borealis-1 trial.

inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.tps4577openalex-snapshot

The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (Apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer.

inferredcites →https://doi.org/10.1200/jco.2020.38.15_suppl.5033openalex-snapshot

Early response marker during pembrolizumab treatment in metastatic urothelial cancer: Temporal shift in peripheral CD4 T cells expressing chemokine receptors.

inferredcites →https://doi.org/10.1371/journal.pone.0057284openalex-snapshot

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting

inferredcites →https://doi.org/10.1371/journal.pone.0135168openalex-snapshot

Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer

inferredcites →https://doi.org/10.1371/journal.pone.0149756openalex-snapshot

Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer

inferredcites →https://doi.org/10.1371/journal.pone.0152673openalex-snapshot

Colorectal Cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing

inferredcites →https://doi.org/10.1371/journal.pone.0153018openalex-snapshot

Circulating Tumor Cell Composition in Renal Cell Carcinoma

inferredcites →https://doi.org/10.1634/theoncologist.2019-0851openalex-snapshot

Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer

inferredcites →https://doi.org/10.17179/excli2019-1683openalex-snapshot

Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer

inferredcites →https://doi.org/10.18632/oncotarget.17765openalex-snapshot

Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models

inferredcites →https://doi.org/10.18632/oncotarget.25998openalex-snapshot

Bladder cancer detection by urinary extracellular vesicle mRNA analysis

inferredcites →https://doi.org/10.3233/blc-170152openalex-snapshot

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation

inferredcites →https://doi.org/10.3322/caac.21492openalex-snapshot

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

inferredcites →https://doi.org/10.3390/cancers11091274openalex-snapshot

Detection of Clinical Mesenchymal Cancer Cells from Bladder Wash Urine for Real-Time Detection and Prognosis

inferredcites →https://doi.org/10.3390/cancers12020353openalex-snapshot

Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer

inferredcites →https://doi.org/10.3390/cancers12051182openalex-snapshot

Prediction of High-Grade Clear Cell Renal Cell Carcinoma Based on Plasma mRNA Profiles in Patients with Localized Pathologic T1N0M0 Stage Disease

inferredcites →https://doi.org/10.3390/cells9061419openalex-snapshot

Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells

inferredcites →https://doi.org/10.7150/jca.37006openalex-snapshot

A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis

inferredcites →https://doi.org/10.7326/m15-0997openalex-snapshot

Urinary Biomarkers for Diagnosis of Bladder Cancer

inferredcites →https://doi.org/10.7554/elife.32143openalex-snapshot

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4757046openalex-extracted

Role of CAPN5 in Tumor Immune Microenvironment Based on Multi-Omics: From BLCA Molecular Subtypes to Therapeutic Prediction

inferred← citeshttps://doi.org/10.1002/adma.202203224openalex-snapshot

Integrated Urinalysis Devices Based on Interface‐Engineered Field‐Effect Transistor Biosensors Incorporated With Electronic Circuits

inferred← citeshttps://doi.org/10.1002/cac2.12224openalex-snapshot

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

inferred← citeshttps://doi.org/10.1002/cac2.12408openalex-snapshot

μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial

inferred← citeshttps://doi.org/10.1002/cncy.22725openalex-snapshot

Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology

inferred← citeshttps://doi.org/10.1002/ctd2.176openalex-snapshot

Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges

inferred← citeshttps://doi.org/10.1002/ctd2.183openalex-snapshot

Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring

inferred← citeshttps://doi.org/10.1002/smtd.202201313openalex-snapshot

Designing Intelligent Nanomaterials to Achieve Highly Sensitive Diagnoses and Multimodality Therapy of Bladder Cancer

inferred← citeshttps://doi.org/10.1007/978-3-032-18790-1_13openalex-snapshot

Next-Generation Sequencing in Kidney, Bladder, and Prostate Pathology

inferred← citeshttps://doi.org/10.1007/s00261-026-05679-8openalex-snapshot

Multi-DECT image-based intra- and peritumoral interpretable radiomics and artificial intelligence models for preoperative prediction of pathological grading of non-muscle-invasive bladder cancer

inferred← citeshttps://doi.org/10.1007/s11033-025-10569-1openalex-snapshot

Liquid biopsy in diagnosis and monitoring of treatment efficacy in patients with small cell lung cancer

inferred← citeshttps://doi.org/10.1007/s11517-024-03031-0openalex-snapshot

Multi-contrast learning-guided lightweight few-shot learning scheme for predicting breast cancer molecular subtypes

inferred← citeshttps://doi.org/10.1007/s12598-022-02074-2openalex-snapshot

Ultrasensitive and accurate diagnosis of urothelial cancer by plasmonic AuNRs‐enhanced fluorescence of near‐infrared Ag 2 S quantum dots

inferred← citeshttps://doi.org/10.1007/s12672-025-04082-xopenalex-snapshot

DCUN1D5 is a novel potential biomarker for predicting the prognosis of bladder cancer

inferred← citeshttps://doi.org/10.1007/s40487-021-00151-7openalex-snapshot

Recommendations for Specimen and Therapy Selection in Colorectal Cancer

inferred← citeshttps://doi.org/10.1016/b978-0-443-24838-2.00007-0openalex-snapshot

Recent advancement in molecular tools for breast cancer diagnosis and therapy decision: Trends in future perspective

inferred← citeshttps://doi.org/10.1016/b978-0-443-27496-1.00013-0openalex-snapshot

Introduction to liquid biopsy

inferred← citeshttps://doi.org/10.1016/b978-0-443-36632-1.00014-6openalex-snapshot

Addressing and overcoming resistance in bladder cancer treatment

inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189199openalex-snapshot

Modeling bladder cancer in the laboratory: Insights from patient-derived organoids

inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115585openalex-snapshot

Colorectal cancer tissue-originated spheroids reveal tumor intrinsic signaling pathways and mimic patient clinical chemotherapeutic response as a rapid and valid model

inferred← citeshttps://doi.org/10.1016/j.bios.2022.114982openalex-snapshot

Tetrahedron supported CRISPR/Cas13a cleavage for electrochemical detection of circular RNA in bladder cancer

inferred← citeshttps://doi.org/10.1016/j.canlet.2025.218157openalex-snapshot

Mitochondria-located circRCP regulates redox homeostasis via stabilizing LRPPRC/SLIRP complex to promote bladder urothelial carcinoma tumorigenesis

inferred← citeshttps://doi.org/10.1016/j.crad.2024.01.031openalex-snapshot

Vesical Imaging-Reporting and Data System (VI-RADS) as a grouping imaging biomarker combined with a decision-tree mode to preoperatively predict the pathological grade of bladder cancer

inferred← citeshttps://doi.org/10.1016/j.jlb.2025.100310openalex-snapshot

Liquid Biopsy: Current advancements in clinical practice for bladder cancer

inferred← citeshttps://doi.org/10.1016/j.labinv.2022.100058openalex-snapshot

p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells

inferred← citeshttps://doi.org/10.1016/j.prp.2024.155369openalex-snapshot

PC4 promotes bladder cancer progression and stemness by directly interacting with Sp1 to transcriptionally activate the Wnt5a/β-catenin pathway

inferred← citeshttps://doi.org/10.1016/j.redox.2021.102201openalex-snapshot

LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis

inferred← citeshttps://doi.org/10.1016/j.urolonc.2026.05.001openalex-snapshot

Emerging role of urinary biomarkers in bladder cancer diagnosis and prognosis

inferred← citeshttps://doi.org/10.1021/acs.analchem.6c01040openalex-snapshot

Self-Assembled DNA Nanoladder-Based Electrochemical Biosensor for Rapid and Sensitive Detection of Bladder Tumor-Related miRNA in Urine

inferred← citeshttps://doi.org/10.1038/s12276-022-00786-0openalex-snapshot

The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer

inferred← citeshttps://doi.org/10.1038/s41374-021-00721-3openalex-snapshot

Driver mutations in ADGRL3 are involved in the evolution of ependymoma

inferred← citeshttps://doi.org/10.1039/d1nr06804kopenalex-snapshot

A novel phage display based platform for exosome diversity characterization

inferred← citeshttps://doi.org/10.1063/5.0159399openalex-snapshot

Phenotyping neuroblastoma cells through intelligent scrutiny of stain-free biomarkers in holographic flow cytometry

inferred← citeshttps://doi.org/10.1093/clinchem/hvae156openalex-snapshot

Machine Learning-Based Detection of Bladder Cancer by Urine cfDNA Fragmentation Hotspots that Capture Cancer-Associated Molecular Features

inferred← citeshttps://doi.org/10.1109/mems64181.2026.11419286openalex-snapshot

AI-Driven Label-Free Exfoliated Tumor Cells Identification Using Hyperspectral Single-Cell Optofluidics

inferred← citeshttps://doi.org/10.1111/boc.202200116openalex-snapshot

Do different exosome biogenesis pathways and selective cargo enrichment contribute to exosomal heterogeneity?

inferred← citeshttps://doi.org/10.1111/cas.16097openalex-snapshot

Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine

inferred← citeshttps://doi.org/10.1186/s11658-023-00442-zopenalex-snapshot

Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer

inferred← citeshttps://doi.org/10.1186/s12967-026-08892-7openalex-snapshot

Liquid biopsy in bladder cancer: towards precision oncology

inferred← citeshttps://doi.org/10.14336/ad.2024.0409openalex-snapshot

Exosomal Proteomics: Unveiling Novel Insights into Lung Cancer

inferred← citeshttps://doi.org/10.21203/rs.3.rs-9223803/v1openalex-snapshot

UroCAD for Detecting Residual Tumor and Predicting Recurrence-Free Survival in Bladder Cancer Patients Post-TURBT

inferred← citeshttps://doi.org/10.3389/fimmu.2023.1097472openalex-snapshot

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine

inferred← citeshttps://doi.org/10.3389/fonc.2021.667212openalex-snapshot

Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer

inferred← citeshttps://doi.org/10.3390/biom14101306openalex-snapshot

Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions

inferred← citeshttps://doi.org/10.3390/bios15020074openalex-snapshot

Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring

inferred← citeshttps://doi.org/10.3390/cancers16040803openalex-snapshot

New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine

inferred← citeshttps://doi.org/10.3390/diagnostics11061102openalex-snapshot

Comparison of Genetic Profiling between Primary Tumor and Circulating Tumor Cells Captured by Microfluidics in Epithelial Ovarian Cancer: Tumor Heterogeneity or Allele Dropout?

inferred← citeshttps://doi.org/10.3390/diagnostics12010131openalex-snapshot

Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer—A Pilot Study

inferred← citeshttps://doi.org/10.3390/genes15111424openalex-snapshot

TERTmonitor Efficacy and Performance in Detecting Mutations by Droplet Digital PCR

inferred← citeshttps://doi.org/10.3390/ijms25168830openalex-snapshot

Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges

inferred← citeshttps://doi.org/10.3390/ijms26199547openalex-snapshot

Translational Insights into NK Immunophenotyping: Comparative Surface Marker Analysis and Circulating Immune Cell Profiling in Cancer Immunotherapy

inferred← citeshttps://doi.org/10.3390/jcm11133855openalex-snapshot

Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study

inferred← citeshttps://doi.org/10.3390/jpm11030237openalex-snapshot

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer

inferred← citeshttps://doi.org/10.3390/pharmaceutics15030774openalex-snapshot

Approved Nanomedicine against Diseases

inferred← citeshttps://doi.org/10.46670/jsst.2025.34.5.410openalex-snapshot

Exosome-Based Diagnostics: Emerging Tools for Early and Non-Invasive Disease Detection

inferred← citeshttps://doi.org/10.51253/pafmj.v73i5.11156openalex-snapshot

To Determine The Diagnostic Accuracy of Urinary Nuclear Matrix Protein 22 in Detection of Recurrence of TCC Bladder Among Patients Who Are on Active Surveillance By Taking Cystoscopic Biopsy As A Gold Standard

inferred← citeshttps://doi.org/10.6004/jnccn.2024.7070openalex-snapshot

Response to EGFR/NTRK/MET Co-Inhibition Guided by Paired NGS in Advanced NSCLC With Acquired EGFR L858R/T790M/C797S Mutations

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.